2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology

被引：1

作者：

Taborsky, Milos ^{[1
,2
]}

Kautzner, Josef ^{[3
]}

Fedorco, Marian ^{[1
,2
]}

Curila, Karol ^{[4
,5
]}

Wunschova, Hanka

Pyszko, Jan ^{[1
,2
]}

Novak, Miroslav ^{[6
,7
]}

Kozak, Milan ^{[8
,9
]}

Valek, Martin ^{[10
,11
]}

Polasek, Rostislav ^{[12
]}

Keprt, Patrik

Kubickova, Milena ^{[13
,14
,15
]}

Plasek, Jiri ^{[16
,17
]}

Gloger, Vit ^{[18
]}

Bulava, Alan ^{[19
,20
]}

Vancura, Vlastimil ^{[21
,22
]}

Skala, Tomas ^{[1
,2
]}

Parizek, Petr ^{[23
,24
]}

Danek, Josef ^{[25
,26
]}

机构：

[1] Univ Palackeho Olomouci, Lekarska Fak, Interni Klin Kardiol 1, IP Pavlova 6, Olomouc 77900, Czech Republic

[2] Fak Nemocnice Olomouc, IP Pavlova 6, Olomouc 77900, Czech Republic

[3] Inst Klin Expt Med, Klin Kardiol, Prague, Czech Republic

[4] Univ Karlovy, Lekarska Fak 3, Kardiol Klin, Prague, Czech Republic

[5] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic

[6] Masarykovy Univ, Lekarska Fak, Interni Kardioangiol Klin 1, Brno, Czech Republic

[7] Fak Nemocnice Sv Anny Brne, Brno, Czech Republic

[8] Masarykovy Univ, Lekarska Fak, Interni Kardiol Klin, Brno, Czech Republic

[9] Fak Nemocnice Brno, Brno, Czech Republic

[10] Univ Karlovy, Lekarska Fak 1, Interni Klin Kardiol & Angiol, Prague, Czech Republic

[11] Vseobecna Fak Nemocnice Praze, Prague, Czech Republic

[12] Krajska Nemocnice Liberec As, Kardiovask Ctr, Liberec, Czech Republic

[13] Univ JE Purkyne Usti Nad Labem, Fak Zdravotnickych, Kardiol Klin, Usti Nad Labem, Czech Republic

[14] Krajska Zdravotni As, Usti Nad Labem, Czech Republic

[15] Masarykova Nemocnice Usti Nad Labem, Oz, Usti Nad Labem, Czech Republic

[16] Ostravske Univ, Lekarska Fak, Interni Kardiol Klin, Ostrava, Czech Republic

[17] Fak Nemocnice Ostrava, Ostrava, Czech Republic

[18] Krajska Nemocnice Tomase Bati Zline, Kardiol Oddeleni, Zlin, Czech Republic

[19] Nemocnice Ceske Budejovice As, Kardiol Oddeleni, Ceske Budejovice, Czech Republic

[20] Jihoceske Univ Ceskych Budejovicich, Zdravotne Socialni Fak, Ceske Budejovice, Czech Republic

[21] Univ Karlova, Lekarska Fak Plzen, Kardiol Klin, Plzen, Czech Republic

[22] Fak Nemocnice Plzen, Plzen, Czech Republic

[23] Univ Karlovy, Lekarska Fak, Interni Kardioangiol Klin 1, L, Hradec Kralove, Czech Republic

[24] Fak Nemocnice Hradec Kralove, Hradec Kralove, Czech Republic

[25] Univ Karlovy, Lekarska Fak 1, Interni Klin, Kardiol Oddeleni, Prague, Czech Republic

[26] Ustredni Vojenska Nemocnice, Prague, Czech Republic

来源：

COR ET VASA | 2023年 / 65卷

关键词：

apixaban; dabigatran; DOACs; edoxaban; NOACs; rivaroxaban;

D O I：

10.33678/cor.2023.024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：23 / 75

页数：53

共 50 条

[31] Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
Huqi, Alda
Zoccali, Carmine
Giugliano, Robert P.
De Caterina, Raffaele
EUROPEAN HEART JOURNAL, 2023, 44 (04) : 322 - 325
[32] Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
Steffel, Jan
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0I) : I32 - I37
[33] Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin
Huang, Huei-Kai
Liu, Peter Pin-Sung
Hsu, Jin-Yi
Lin, Shu-Man
Peng, Carol Chiung-Hui
Wang, Jen-Hung
Yeh, Jih-, I
Loh, Ching-Hui
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (02):
[34] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion
Itainen, Saga
Lehto, Mika
Vasankari, Tuija
Mustonen, Pirjo
Kotamaki, Mervi
Numminen, Anna
Lahtela, Heli
Bah, Aissa
Hartikainen, Juha
Hekkala, Anna-Mari
Airaksinen, Juhani K. E.
EUROPACE, 2018, 20 (04): : 565 - 568
[35] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding
Kwon, Soonil
Lee, So-Ryoung
Choi, Eue-Keun
Lee, Euijae
Jung, Jin-Hyung
Han, Kyung-Do
Cha, Myung-Jin
Oh, Seil
Lip, Gregory Y. H.
STROKE, 2021, 52 (02) : 511 - 520
[36] Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
Caldeira, Daniel
Costa, Joo
Ferreira, Joaquim J.
Lip, Gregory Y. H.
Pinto, Fausto J.
CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (07) : 582 - 590
[37] Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation
Jelonek, Olga
Gorczyca, Iwona
Baczek, Michal
Kosmider, Pawel
Wozakowska-Kaplon, Beata
KARDIOLOGIA POLSKA, 2018, 76 (07) : 1073 - 1080
[38] Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
Liu, Fuwei
Yang, Yunyao
Cheng, Winglam
Ma, Jianyong
Zhu, Wengen
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[39] Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Hirosuke Yamaji
Takashi Murakami
Kazuyoshi Hina
Shunich Higashiya
Hiroshi Kawamura
Masaaki Murakami
Shigeshi Kamikawa
Issei Komtasubara
Shozo Kusachi
Clinical Drug Investigation, 2016, 36 : 837 - 848
[40] Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study
Xing, Lucas Yixi
Barcella, Carlo Alberto
Sindet-Pedersen, Caroline
Bonde, Anders Nissen
Gislason, Gunnar Hilmar
Olesen, Jonas Bjerring
THROMBOSIS RESEARCH, 2019, 178 : 101 - 109

← 1 2 3 4 5 →